SYBX
Price:
$1.15
Market Cap:
$13.45M
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratum...[Read more]
Industry
Biotechnology
IPO Date
2015-09-30
Stock Exchange
NASDAQ
Ticker
SYBX
According to Synlogic, Inc.’s latest financial reports and current stock price. The company's current ROE is -26.47%. This represents a change of 256.94% compared to the average of -7.42% of the last 4 quarters.
The mean historical ROE of Synlogic, Inc. over the last ten years is -67.50%. The current -26.47% ROE has changed -60.78% with respect to the historical average. Over the past ten years (40 quarters), SYBX's ROE was at its highest in in the June 2024 quarter at 12.59%. The ROE was at its lowest in in the March 2024 quarter at -236.88%.
Average
-67.50%
Median
-45.50%
Minimum
-183.19%
Maximum
-29.39%
Discovering the peaks and valleys of Synlogic, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 98.99%
Maximum Annual ROE = -29.39%
Minimum Annual Increase = -188.99%
Minimum Annual ROE = -183.19%
| Year | ROE | Change |
|---|---|---|
| 2024 | -183.19% | 36.41% |
| 2023 | -134.29% | 71.00% |
| 2022 | -78.53% | 98.99% |
| 2021 | -39.46% | -19.63% |
| 2020 | -49.10% | 58.30% |
| 2019 | -31.02% | -20.52% |
| 2018 | -39.03% | -17.80% |
| 2017 | -47.48% | 9.09% |
| 2016 | -43.52% | 48.11% |
| 2015 | -29.39% | -188.99% |
The current ROE of Synlogic, Inc. (SYBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-132.01%
5-year avg
-96.92%
10-year avg
-67.50%
Synlogic, Inc.’s ROE is greater than Lixte Biotechnology Holdings, Inc. (-308.56%), greater than Allarity Therapeutics, Inc. (-112.05%), greater than Lexaria Bioscience Corp. (-149.35%), less than Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (42.42%), greater than Cingulate Inc. (-842.45%), less than Curis, Inc. (354.21%), greater than Entero Therapeutics, Inc. (-31.69%), greater than Kairos Pharma, Ltd. (-79.19%), greater than BriaCell Therapeutics Corp. (-439.74%), greater than Processa Pharmaceuticals, Inc. (-342.35%),
| Company | ROE | Market cap |
|---|---|---|
| -308.56% | $19.34M | |
| -112.05% | $16.85M | |
| -149.35% | $20.27M | |
| 42.42% | $13.21M | |
| -842.45% | $22.09M | |
| 354.21% | $17.45M | |
| -31.69% | $11.06M | |
| -79.19% | $18.86M | |
| -439.74% | $23.06M | |
| -342.35% | $15.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synlogic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synlogic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Synlogic, Inc.'s ROE?
How is the ROE calculated for Synlogic, Inc. (SYBX)?
What is the highest ROE for Synlogic, Inc. (SYBX)?
What is the 3-year average ROE for Synlogic, Inc. (SYBX)?
What is the 5-year average ROE for Synlogic, Inc. (SYBX)?
How does the current ROE for Synlogic, Inc. (SYBX) compare to its historical average?